206 related articles for article (PubMed ID: 10489356)
1. Treatment of HSV-1 infection with immunoglobulin or acyclovir: comparison of their effects on viral spread, latency, and reactivation.
LeBlanc RA; Pesnicak L; Godleski M; Straus SE
Virology; 1999 Sep; 262(1):230-6. PubMed ID: 10489356
[TBL] [Abstract][Full Text] [Related]
2. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
[TBL] [Abstract][Full Text] [Related]
3. Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1.
Halford WP; Gebhardt BM; Carr DJ
Virology; 1997 Nov; 238(1):53-63. PubMed ID: 9375008
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus type 1 envelope subunit vaccine not only protects against lethal virus challenge, but also may restrict latency and virus reactivation.
Rajcáni J; Sabó A; Mucha V; Kostál M; Compel P
Acta Virol; 1995 Feb; 39(1):37-49. PubMed ID: 7572468
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic and therapeutic effects of human immunoglobulin on the pathobiology of HSV-1 infection, latency, and reactivation in mice.
Dalai SK; Pesnicak L; Miller GF; Straus SE
J Neurovirol; 2002 Feb; 8(1):35-44. PubMed ID: 11847590
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
[TBL] [Abstract][Full Text] [Related]
7. Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo.
Sawtell NM; Thompson RL; Stanberry LR; Bernstein DI
J Infect Dis; 2001 Oct; 184(8):964-71. PubMed ID: 11574910
[TBL] [Abstract][Full Text] [Related]
8. Development of an aciclovir implant for the effective long-term control of herpes simplex virus type-1 infection in Vero cells and in experimentally infected SKH-1 mice.
Johnson TP; Frey R; Modugno M; Brennan TP; Margulies BJ
Int J Antimicrob Agents; 2007 Nov; 30(5):428-35. PubMed ID: 17851051
[TBL] [Abstract][Full Text] [Related]
9. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
Itahashi M; Higaki S; Shimomura Y
Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
[TBL] [Abstract][Full Text] [Related]
10. Effect of acyclovir on thermal stress-induced herpesvirus reactivation.
Gebhardt BM; Kaufman HE; Hill JM
Curr Eye Res; 2004; 29(2-3):137-44. PubMed ID: 15512960
[TBL] [Abstract][Full Text] [Related]
11. The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice.
LeBlanc RA; Pesnicak L; Godleski M; Straus SE
J Infect Dis; 1999 Sep; 180(3):594-9. PubMed ID: 10438344
[TBL] [Abstract][Full Text] [Related]
12. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
[TBL] [Abstract][Full Text] [Related]
13. [Establishment of a cell model system of herpes simplex virus type II latent infection and reactivation in SH-SY5Y cells].
Sun Z; Yang H; Shi Y; Wei M; Xian J; Hu W
Wei Sheng Wu Xue Bao; 2010 Jan; 50(1):98-106. PubMed ID: 20344947
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic acyclovir effectively reduces herpes simplex virus type 1 reactivation after exposure of latently infected mice to ultraviolet B.
Blatt AN; Laycock KA; Brady RH; Traynor P; Krogstad DJ; Pepose JS
Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3459-65. PubMed ID: 8225880
[TBL] [Abstract][Full Text] [Related]
15. Acetylsalicylic acid reduces viral shedding induced by thermal stress.
Gebhardt BM; Varnell ED; Kaufman HE
Curr Eye Res; 2004; 29(2-3):119-25. PubMed ID: 15512958
[TBL] [Abstract][Full Text] [Related]
16. Latent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals.
van Velzen M; van Loenen FB; Meesters RJ; de Graaf M; Remeijer L; Luider TM; Osterhaus AD; Verjans GM
J Infect Dis; 2012 May; 205(10):1539-43. PubMed ID: 22457282
[TBL] [Abstract][Full Text] [Related]
17. The effect of topical ocular corticosteroid administration in dogs with experimentally induced latent canine herpesvirus-1 infection.
Ledbetter EC; Kice NC; Matusow RB; Dubovi EJ; Kim SG
Exp Eye Res; 2010 Jun; 90(6):711-7. PubMed ID: 20223234
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of herpes simplex virus reactivation by dipyridamole in a mouse model.
Hay KA; Gaydos A; Tenser RB
J Med Virol; 1996 Oct; 50(2):198-203. PubMed ID: 8915888
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Voltage-Gated Sodium Channel Activity in Human Dorsal Root Ganglion Neurons by Herpesvirus Quiescent Infection.
Zhang Q; Martin-Caraballo M; Hsia SV
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694955
[TBL] [Abstract][Full Text] [Related]
20. A temporal analysis of acyclovir inhibition of induced herpes simplex virus type 1 In vivo reactivation in the mouse trigeminal ganglia.
Sawtell NM; Bernstein DI; Stanberry LR
J Infect Dis; 1999 Sep; 180(3):821-3. PubMed ID: 10438371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
